Wednesday, November 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

BlackRock Throgmorton Stock: Mixed Performance Amid Strategic Shifts

Andreas Sommer by Andreas Sommer
August 12, 2025
in Stocks
0
BlackRock Throgmorton Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

The BlackRock Throgmorton Trust reported modest growth in July 2025, with its net asset value (NAV) rising just 0.2%, lagging behind its benchmark’s 0.7% gain. While the share price outperformed the NAV with a 0.7% increase, the trust missed out on a lucrative acquisition opportunity—a company it didn’t hold surged 75% on a takeover bid before issuing a profit warning in August. The UK-focused trust faced headwinds in the property sector, with holdings like Bellway and Grafton dragging performance due to weaker industry data. In response, management reduced exposure to UK cyclical stocks and increased short positions while expanding international investments to 12% of the portfolio. Positive contributions came from Alpha Group International, acquired by a payments firm, and Boku, which raised its annual forecast amid a shift toward local payment methods.

Buybacks Signal Confidence

The trust continues its aggressive share buyback strategy, purchasing 15,000 shares at an average price of 599.86 pence in early August. With over 26 million shares now held in treasury—26.03% of total issued capital—the move underscores management’s belief in undervaluation. The reduced float enhances per-share value, reflecting a disciplined approach to capital allocation. Gross market exposure stood at 117% by July’s end, with net exposure at 108%, as the trust maintains a defensive stance amid market volatility.

Ad

BlackRock Throgmorton Stock: Buy or Sell?! New BlackRock Throgmorton Analysis from November 12 delivers the answer:

The latest BlackRock Throgmorton figures speak for themselves: Urgent action needed for BlackRock Throgmorton investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 12.

BlackRock Throgmorton: Buy or sell? Read more here...

Tags: BlackRock Throgmorton
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Trane Technologies Stock

Trane Technologies Stock: AI Lab Fuels Growth Ambitions

Barrick Gold Stock

Barrick Gold Stock: Record Profits Amid Market Turbulence

Plug Power Stock

Plug Power Stock: Mixed Q2 Results Spark Uncertainty

Recommended

Eli Lilly and Stock

Eli Lilly Secures Dual Regulatory Wins to Fuel Growth

4 weeks ago
Seres Therapeutics Stock

Seres Therapeutics: A Stock Poised for Breakout or Breakdown?

3 months ago
Apple Stock

Apple Faces Legal Challenge Over AI Training Data

1 month ago
Biotechnology Stock Bull Market

REGENXBIOs Breakthrough in Duchenne Muscular Dystrophy Treatment

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Novo Nordisk Shares: Sustainable Recovery or Temporary Bounce?

Tuniu Faces Nasdaq Delisting Deadline as Shares Languish

ASML’s Asian Strategy: Balancing Korean Expansion Against Chinese Headwinds

Rite Aid’s Final Chapter: Shareholders Face Total Wipeout

Allakos Reaches Corporate Endpoint with Concentra Acquisition

Nel ASA Shares Surge on Landmark Hydrogen Contract

Trending

Apex Critical Metals Stock
Commodities

Uncovering Apex Critical Metals: A Potential Game-Changer in Essential Resources

by Andreas Sommer
November 12, 2025
0

While terms like niobium and rare earth elements might sound like scientific jargon to many, these materials...

Red Cat Stock

Red Cat Holdings Poised for Stellar Quarterly Results

November 12, 2025
Take-Two Stock

Take-Two Shares Tumble as Grand Theft Auto VI Faces New Delay

November 12, 2025
Novo Nordisk Stock

Novo Nordisk Shares: Sustainable Recovery or Temporary Bounce?

November 12, 2025
Tuniu Stock

Tuniu Faces Nasdaq Delisting Deadline as Shares Languish

November 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Uncovering Apex Critical Metals: A Potential Game-Changer in Essential Resources
  • Red Cat Holdings Poised for Stellar Quarterly Results
  • Take-Two Shares Tumble as Grand Theft Auto VI Faces New Delay

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com